About

Main Content

1959
Founded as “Bespak” supplying valves for cosmetics and consumer markets

1968
Gained contract with GSK for Ventolin thus entering the pharmaceutical market

1975
Moved to King’s Lynn where Bespak remains today

1997
Awarded Diskus® manufacturing contract by GSK

1999
Launched HFA valve to replace CFC variant

2007
Group’s name changed to Consort Medical plc

2009
Acquired The Medical House, a specialist in auto injectors

2010
500 millionth Diskus® device manufactured for GSK

2011
Entered point of care diagnostics market in partnership with Atlas Genetics

2012
Awarded contract with Nicoventures for licensed nicotine delivery product

2013
Unveiled Syrina®, Vapoursoft® and Lila® range of innovative injection devices
Secured first MHRA licence for commercial drug handling

2014
Regulatory approval and launch of Bespak’s first auto-injector (for Dr. Reddy’s)
Agreement with SteadyMed for development of wearable infusion delivery device
Unveiled Lapas® range of innovative bolus injection devices

2015
2 billionth HFA MDI Valve manufactured

2016
Signed Significant development and manufacturing collaboration agreement with Oxular “formerly Precision Ocular”
Regulatory approval and UK launch for UCB’s Cimzia Auto injector with core Bespak technology
Signed AstraZeneca scale-up and commercial supply agreement for Bespak proprietary pMDI valves and actuators